Cefpirome Sulphate Injection 1 gm

Cefpirome binds to one or more of the penicillinbinding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Cefpirome is rapidly and widely distributed in body fluids and achieves excellent tissue penetration reaching concentrations which exceed the minimum inhibitory concentrations for most pathogens

Indications

Infections caused by Cefpirome-sensitive organisms: Lower respiratory tract infections Complicated upper and lower urinary tract infections Bacteraemia/Septicaemia Infections in neutropenic & immunocompromised patients. Skin and soft tissue infections. Severe infections in intensive care patients.

Contraindications

Cefpirome must not be used in patients with hypersensivity to antibiotics of the cephalosporin group. Cefpirome must not be used during pregnancy. Breast-feeding should be discontinued during treatment with Cefpirome.

Other Information:

Export Availability: Corex API Export India offers commercial supply of Cefpirome Sulphate Injection 1 gm to licensed importers, distributors, and healthcare facilities worldwide. Accompanied by standard Certificate of Analysis (COA) and batch documentation.